Calendar Laboratorios Farmaceuticos Rovi, S.A.

Equities

ROVI

ES0157261019

Market Closed - BME 11:35:28 2024-04-18 am EDT 5-day change 1st Jan Change
79.45 EUR -1.55% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. -2.99% +31.98%

Chart calendar Laboratorios Farmaceuticos Rovi, S.A.

e9fa0c0308e7d51492a138da7c684.HGac5i7_nPQqkVsb-m_A4imk_ExDmcc4nK8dPjo74g8.dAyplliUqsZ1_jJUzQ6IiWDhrjwmqp96zOwpX3FY0lpsNNWAZobXzXDJCg~4a5d65996432bd642d7619551f570287

Upcoming events on Laboratorios Farmaceuticos Rovi, S.A.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-07-23 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)

Past events on Laboratorios Farmaceuticos Rovi, S.A.

2024-02-27 09:00 am Q4 2023 Earnings Call
2024-02-26 Q4 2023 Earnings Release Pre-market
2023-11-07 Q3 2023 Earnings Call
2023-11-07 Q3 2023 Earnings Release Pre-market
2023-07-26 09:00 am Q2 2023 Earnings Call
2023-07-25 Q2 2023 Earnings Release Pre-market
2023-07-02 Ex-dividend day for final dividend
2023-06-14 05:00 am Annual General Meeting
2023-05-09 Q1 2023 Earnings Call
2023-05-09 Q1 2023 Earnings Release Pre-market
2023-02-21 04:00 am FY 2022 Earnings Call
2023-02-20 FY 2022 Earnings Release Pre-market
2022-11-23 04:00 am Capital Market Day
2022-11-03 Q3 2022 Earnings Call
2022-11-03 Q3 2022 Earnings Release Pre-market
2022-07-27 09:00 am Interim 2022 Earnings Call
2022-07-26 Interim 2022 Earnings Release Pre-market
2022-07-04 Ex-dividend day for final dividend
2022-05-10 Q1 2022 Earnings Call
2022-05-10 Q1 2022 Earnings Release Pre-market

Past dividends on Laboratorios Farmaceuticos Rovi, S.A.

2023-07-02 Annual 1.047978 EUR
2022-07-04 Annual 0.774036 EUR
2021-07-04 Annual 0.308772 EUR
2020-11-16 Annual 0.141831 EUR
2019-07-01 Annual 0.064638 EUR
2018-07-02 Annual 0.097767 EUR
2017-07-02 Annual 0.14823 EUR
2016-06-29 Annual 0.11259 EUR
2015-07-01 Annual 0.1352 EUR
2014-07-02 Annual 0.127348 EUR

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
381
369
3.33%
420
417
0.78%
649
633
2.52%
818
788
3.78%
830
823
0.79%

822

EBITDA
Million EUR
Released
Forecast
Spread
60,9
58,2
4.5%
94,3
88,5
6.59%
203
193
5.23%
279
252
10.47%
245
239
2.36%

244

EBIT
Million EUR
Released
Forecast
Spread
42,6
40,6
5.11%
74,7
69,9
6.88%
181
171
5.95%
256
230
11.48%
220
214
2.67%

218

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
41,9
40,1
4.44%
72,6
67,9
6.93%
183
171
7.03%
258
226
14.07%
220
217
1.8%

213

Net income
Million EUR
Released
Forecast
Spread
39,3
36,1
8.71%
61,1
60,4
1.07%
153
140
9.42%
200
183
9.36%
170
167
2.05%

167

EPS
EUR
Released
Forecast
Spread
0,71
0,62
15.01%
1,10
1,09
0.72%
2,76
2,51
10.05%
3,73
3,35
11.19%
3,20
3,12
2.58%

3,21

Announcement Date26/02/2024/02/2123/02/2221/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4
Net sales
Million EUR
Released
Forecast
Spread
191
191
-0.08%
290
277
4.73%
185
174
6.55%
206
201
2.53%
175
173
1.32%
380
377
0.78%
195
193
0.91%
242
223
8.67%
202
195
3.15%
179
174
3.01%
381
377
1.02%
214
208
3.05%
235
226
3.91%
EBITDA
Million EUR
Released
Forecast
Spread
42,4
39,8
6.67%
74,0
74,7
-0.94%
63,4
55,5
14.09%
74,3
68,5
8.47%
41,5
38,5
7.7%
116
113
2.57%
58,1
55,2
5.25%
105
82,1
27.71%
66,5
59,1
12.57%
30,6
24,2
26.62%
97,1
93,0
4.41%
74,1
66,8
10.93%
73,3
71,1
3.14%
EBIT
Million EUR
Released
Forecast
Spread
32,9
30,3
8.63%
63,2
65,6
-3.6%
58,2
49,8
16.8%
68,7
62,0
10.82%
35,7
33,2
7.33%
104
102
2.45%
52,5
49,6
5.89%
99,0
74,5
32.91%
60,7
52,8
14.91%
24,5
19,0
28.98%
85,2
81,0
5.19%
68,2
58,5
16.58%
66,7
66,0
1.06%
Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread






58,3
44,1
32.15%
68,9
61,7
11.71%












61,2
55,3
10.67%












Net income
Million EUR
Released
Forecast
Spread
29,6
27,3
8.49%
51,0
50,1
1.84%
54,1
36,1
50.18%
53,0
49,5
7.17%
27,6
25,5
8.2%
80,6
78,6
2.57%
40,9
38,2
7.02%
78,2
59,8
30.82%
47,5
42,3
12.29%
19,1
13,6
40.1%
66,6
63,0
5.71%
52,2
45,5
14.77%
51,5
47,7
8.04%
EPS
EUR
Released
Forecast
Spread






0,98
0,61
60.66%






























Announcement Date27/07/2028/07/2123/02/2211/05/2227/07/2227/07/2204/11/2221/02/2310/05/2326/07/2326/07/2308/11/2327/02/24

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. Calendar Laboratorios Farmaceuticos Rovi, S.A.